Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 4

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(5)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT04688866Unknown

Investigation Into the Microorganisms in Pregnant Women

Role: collaborator

NCT04587180Completed

Cutting-through at the Greater Tuberosity

Role: collaborator

NCT02424630Not ApplicableCompleted

Interscalene Brachial Plexus Block Combined With Suprascapular Nerve Block

Role: collaborator

NCT04398589Phase 4Completed

The Effect of Dexmedetomidine for Suprascapular Nerve Block With Axillary Nerve Block

Role: collaborator

NCT04138355Not ApplicableCompleted

The Clinical Utility of Extracorporeal Shock Wave Therapy on Hand Burns

Role: collaborator

NCT04125108Not ApplicableCompleted

The Effect of a Pulmonary Rehabilitation on Lung Function and Exercise Capacity in Patients With Burn

Role: collaborator

NCT04187586Completed

Effect of Extracorporeal Shock Wave Therapy for Burn Scar Charateristics

Role: collaborator

NCT03597633Unknown

Tenofovir Combination or Mono-therapy for MDR CHB

Role: collaborator

NCT01839292Not ApplicableCompleted

ComVi and D-type Stent in Malignant GOO

Role: collaborator

NCT01478516Not ApplicableUnknown

Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy

Role: collaborator

NCT01037842Phase 3Completed

Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus

Role: collaborator

All 11 trials loaded